Cosmetic CBD Has Insurance Industry Spooked: The Dope Before You Toke
Executive Summary
Marketing CBD-containing cosmetics in today’s hazy legal and regulatory environment carries risks beyond what insurance carriers may be willing to take on. Kenneth Hegel of Cosmetic Insurance Services, a division of brokerage firm Frenkel & Company – an Epic Company, discusses the dilemma facing underwriters and criteria companies can meet to improve their insurance prospects.
You may also be interested in...
CBD Cosmetics Rush Is ‘Fast And Furious,’ But Don’t Skimp On Testing, Experts Say
Speakers at ICMAD’s regulatory workshop in New York stressed the importance of CBD testing in today’s highly uncertain climate for hemp-based cosmetics. While rigorous testing can drive up costs and slow the path to market, it also could significantly reduce chances of safety, regulatory or legal issues down the line.
Interested In Using CBD Or Probiotics In Cosmetics? Ask Yourself Why – FDA’s Linda Katz
The answer to the ‘why’ question can help clarify whether a company is marketing a cosmetic or an unapproved drug, FDA’s cosmetics office director advised attendees at ICMAD’s 38th annual regulatory workshop in New York.
Cosmetics Firms ‘Chomping At The Bit’ To Use CBD, But Do So At Own Peril, Attorney Says
Tucker Ellis attorney Ronie Schmelz discusses uncertainties companies face in marketing CBD-containing cosmetics and measures they can take to mitigate risks ahead of expected regulatory guidance.